http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2345773-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8b33bb117bb6315cd06c75a3ccc0227 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 |
| filingDate | 2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_272fdc19cba94f3ecf1cb1e75a586778 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca56b9fd4951f7383b4f6a932e68a721 |
| publicationDate | 2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2345773-C2 |
| titleOfInvention | Minimal flow inhalational anesthesia method |
| abstract | FIELD: medicine; traumatology and orthopaedics. n SUBSTANCE: minimal flow anaesthesia based on application of Sevoflurane and fast restoration recovery of vital functions within near-term postoperative period includes as followed. Minimal flow inhalation anaesthesia 0.5 l/min is based on application of Sevoflurane of MAC 0.5-1.0 in oxygen-air mixture. Anaesthesia is deepened with Suprastine premedication in dosage 0.25 mg/kg. 15 minutes prior to be induced to anaesthesia, Ringer's solution is intravenously injected in dosage 7-8 ml/kg. For initial narcosis, Atropine dosed 0.012 mg/kg and Fentanyl dosed 1.32 mkg/kg are used. Induction is represented with Propovan 1% introduction in dosage 2.6-3.2 mg/kg followed with Esmeron dosed 0.65 mg/kg. After myoplegia is ensued in 90 seconds, laryngoscopy and intubation of trachea follow. Myoplegia is maintained with infused Esmeron dosed 0.26-0.37 mg/kg/h. Artificial pulmonary ventilation is carried out through endotracheal tube in IPPV reverse-circuit mode with respiratory volume 7-8 ml/kg and respiratory minute volume 80-90 ml/kg, FiO 2 =35-40% with controlled SpO 2 and EtCO 2 . High-calcium lime is used as a sorbent. Spondylosyndesis operation in open pneumothorax at pneumothorax application stage implies infusion of balanced potassium magnesium aspartate in amount 3-3.5 ml/kg. 2 minutes prior to collaber lung is straightened, anaesthesia is deepened by Fentanyl introduction in dosage 1.25-1.5 mkg/kg. Additionally Ingitril 30 UNITS is introduced to the patients suffering from complicated spine injury. n EFFECT: managed adequate anaesthetic protection with minimal pharmacological effect on patient's homeostasis. n 4 cl, 2 ex |
| priorityDate | 2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.